Kymera Therapeutics, Inc. (KYMR)
85.40
+0.47
(+0.55%)
USD |
NASDAQ |
Apr 02, 16:00
85.34
-0.06
(-0.07%)
After-Hours: 20:00
Kymera Therapeutics Market Cap : 7.006B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 19.73B |
| Gilead Sciences, Inc. | 172.67B |
| Regeneron Pharmaceuticals, Inc. | 78.97B |
| Structure Therapeutics, Inc. | 4.035B |
| ACADIA Pharmaceuticals, Inc. | 3.764B |
Market Cap Related Metrics
| PS Ratio | 184.83 |
| PEG Ratio | -0.9717 |
| Price to Book Value | 4.435 |
| Price | 85.40 |
| Earnings Yield | -4.29% |
| PEGY Ratio | -0.9717 |